J. Michael Bishop | |
---|---|
Born | John Michael Bishop February 22, 1936 York, Pennsylvania, U.S. |
Alma mater | Gettysburg College (Bachelors) Harvard University (MD) |
Known for | Oncogene Virus |
Awards |
|
Scientific career | |
Fields | Virology |
Institutions | |
Website | profiles |
John Michael Bishop (born February 22, 1936) is an American immunologist and microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine with Harold E. Varmus. [1] He serves as an active faculty member at the University of California, San Francisco (UCSF), where he also served as chancellor from 1998 to 2009. [2] [3] [4] [5] [6]
Bishop was born in York, Pennsylvania. He attended Gettysburg College as an undergraduate, where he was a brother of the Theta-Pi Zeta chapter of Lambda Chi Alpha fraternity. He later attended Harvard University Medical School, where he earned an MD in 1962. [7]
Bishop began his career working for the National Institute of Allergy and Infectious Diseases, a part of the National Institutes of Health. He then spent a year working for the Heinrich Pette Institute in Hamburg, Germany before joining the faculty of the University of California, San Francisco in 1968. [3] Bishop has remained on the school's faculty since 1968, and was chancellor of the university from 1998 to 2009. [5] He is director of the Bishop Lab. [8]
He became the eighth chancellor of UCSF in 1998. He oversaw one of UCSF's major transition and growth periods, including the expanding Mission Bay development and philanthropic support recruitment. During his tenure, he unveiled the first comprehensive, campus-wide, strategic plan to promote diversity and foster a supportive work environment. During this time, UCSF also adopted a new mission: advancing health worldwide™. [9]
Much of this work was conducted jointly with Harold Varmus in a notably long scientific partnership. Their best-known accomplishment [10] was the identification of a cellular gene (c-src) that gave rise to the v-src oncogene of Rous Sarcoma Virus, a cancer-causing virus first isolated from a chicken sarcoma by Peyton Rous in 1910. Their discovery triggered the identification of many other cellular proto-oncogenes—progenitors of viral oncogenes and targets for mutations that drive human cancers.
Bishop is best known for his Nobel-winning work on retroviral oncogenes. Working with Harold E. Varmus in the 1980s, he discovered the first human oncogene, c-Src. Their findings allowed the understanding of how malignant tumors are formed from changes to the normal genes of a cell. These changes can be produced by viruses, by radiation, or by exposure to some chemicals. [4] [11] [12] [13]
Bishop is a member of the National Academy of Sciences, [14] the American Academy of Arts and Sciences, [15] and the American Philosophical Society. [16]
Bishop is also a recipient of National Medal of Science in 2003. [6] That same year, his book "How to win the Nobel Prize: An Unexpected Life in Science" was published. He was elected Foreign Member of the Royal Society (ForMemRS) in 2008. [17] In 2020, Bishop received from the UC Berkeley Academic Senate the Clark Kerr Award for distinguished leadership in higher education. [18]
The University of California, San Francisco Archives and Special Collections houses a collection of J. Michael Bishop papers, including his laboratory research notebooks, writings, photographs, and other material. [19]
An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated, or expressed at high levels.
A retrovirus is a type of virus that inserts a DNA copy of its RNA genome into the DNA of a host cell that it invades, thus changing the genome of that cell. After invading a host cell's cytoplasm, the virus uses its own reverse transcriptase enzyme to produce DNA from its RNA genome, the reverse of the usual pattern, thus retro (backwards). The new DNA is then incorporated into the host cell genome by an integrase enzyme, at which point the retroviral DNA is referred to as a provirus. The host cell then treats the viral DNA as part of its own genome, transcribing and translating the viral genes along with the cell's own genes, producing the proteins required to assemble new copies of the virus. Many retroviruses cause serious diseases in humans, other mammals, and birds.
Retroposons are repetitive DNA fragments which are inserted into chromosomes after they had been reverse transcribed from any RNA molecule.
The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.
Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
Howard Martin Temin was an American geneticist and virologist. He discovered reverse transcriptase in the 1970s at the University of Wisconsin–Madison, for which he shared the 1975 Nobel Prize in Physiology or Medicine with Renato Dulbecco and David Baltimore.
An oncovirus or oncogenic virus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, when the term "oncornaviruses" was used to denote their RNA virus origin. With the letters "RNA" removed, it now refers to any virus with a DNA or RNA genome causing cancer and is synonymous with "tumor virus" or "cancer virus". The vast majority of human and animal viruses do not cause cancer, probably because of longstanding co-evolution between the virus and its host. Oncoviruses have been important not only in epidemiology, but also in investigations of cell cycle control mechanisms such as the retinoblastoma protein.
Rous sarcoma virus (RSV) is a retrovirus and is the first oncovirus to have been described. It causes sarcoma in chickens.
Francis Peyton Rous was an American pathologist at the Rockefeller University known for his works in oncoviruses, blood transfusion and physiology of digestion. A medical graduate from the Johns Hopkins University, he was discouraged from becoming a practicing physician due to severe tuberculosis. After three years of working as an instructor of pathology at the University of Michigan, he became dedicated researcher at the Rockefeller Institute for Medical Research for the rest of his career.
The gag-onc fusion protein is a general term for a fusion protein formed from a group-specific antigen ('gag') gene and that of an oncogene ('onc'), a gene that plays a role in the development of a cancer. The name is also written as Gag-v-Onc, with "v" indicating that the Onc sequence resides in a viral genome. Onc is a generic placeholder for a given specific oncogene, such as C-jun..
v-Src is a gene found in Rous sarcoma virus (RSV) that encodes a tyrosine kinase that causes a type of cancer in chickens.
Proto-oncogene tyrosine-protein kinase Src, also known as proto-oncogene c-Src, or simply c-Src, is a non-receptor tyrosine kinase protein that in humans is encoded by the SRC gene. It belongs to a family of Src family kinases and is similar to the v-Src gene of Rous sarcoma virus. It includes an SH2 domain, an SH3 domain and a tyrosine kinase domain. Two transcript variants encoding the same protein have been found for this gene.
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog, also known as FGR, is a protein which in humans is encoded by the FGR gene.
Avian sarcoma leukosis virus (ASLV) is an endogenous retrovirus that infects and can lead to cancer in chickens; experimentally it can infect other species of birds and mammals. ASLV replicates in chicken embryo fibroblasts, the cells that contribute to the formation of connective tissues. Different forms of the disease exist, including lymphoblastic, erythroblastic, and osteopetrotic.
Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.
Chickens and their eggs have been used extensively as research models throughout the history of biology. Today they continue to serve as an important model for normal human biology as well as pathological disease processes.
Joan S. Brugge is the Louise Foote Pfeiffer Professor of Cell Biology and the Director of the Ludwig Center at Harvard Medical School, where she also served as the Chair of the Department of Cell Biology from 2004 to 2014. Her research focuses on cancer biology, and she has been recognized for her explorations into the Rous sarcoma virus, extracellular matrix adhesion, and epithelial tumor progression in breast cancer.
The UCSF School of Medicine is the medical school of the University of California, San Francisco and is located at the base of Mount Sutro on the Parnassus Heights campus in San Francisco, California. Founded in 1864 by Hugh Toland, it is the oldest medical school in California and in the western United States. U.S. News & World Report ranked the school fifth in research training and fifth in primary care training. Six members of the UCSF faculty have received the Nobel Prize in Physiology or Medicine and five have received the National Medal of Science.
Daisy Roulland-Dussoix was a Swiss molecular microbiologist. She was one of the discoverers of restriction enzymes during her doctoral studies. There is controversy over whether she should have received the 1978 Nobel prize in Physiology and Medicine, which was awarded to Hamilton O. Smith, Daniel Nathans, and Werner Arber.
Donald "Don" Emil Ganem is an American physician, virologist, professor emeritus of microbiology and medicine, and former global head of infectious disease research at Novartis Institutes for BioMedical Research (NIBR).